Retatrutide
Investigational triple-agonist medicine in clinical trials. Not FDA-approved.
- Type
- Investigational medicine
- Research area
- Metabolic research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About Retatrutide
Investigational triple-agonist medicine in clinical trials. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is Retatrutide an FDA-approved medicine?
No. Retatrutide is not an FDA-approved medicine. Research stage: Clinical trials.
Does EKO Labs sell Retatrutide?
No. EKO Labs does not sell Retatrutide or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use Retatrutide?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
Related compounds
C194H312N54O59S2CagrilintideCagrilintide
Investigational amylin analog in clinical trials. Not FDA-approved.
C192H289N47O61SurvodutideSurvodutide
Investigational medicine in clinical trials. Not FDA-approved.
C101H152N28O22S2MOTS-cMOTS-c
A mitochondria-derived peptide studied in metabolic research.